XOMA Corp (XOMA)
25.36
-0.28
(-1.09%)
USD |
NASDAQ |
Apr 25, 16:00
26.44
+1.08
(+4.26%)
After-Hours: 20:00
XOMA Cash from Investing (Quarterly): 5.511M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.511M |
| September 30, 2023 | 5.494M |
| June 30, 2023 | -4.482M |
| March 31, 2023 | -7.234M |
| December 31, 2022 | -15.25M |
| September 30, 2022 | 0.026M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -5.00M |
| December 31, 2021 | -6.00M |
| September 30, 2021 | -7.00M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -13.50M |
| December 31, 2020 | -0.20M |
| September 30, 2020 | -0.009M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -13.00M |
| June 30, 2019 | -6.00M |
| March 31, 2019 | -0.30M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -15.01M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.016M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.024M |
| June 30, 2017 | 0.801M |
| March 31, 2017 | 0.813M |
| December 31, 2016 | -0.024M |
| September 30, 2016 | 0.622M |
| June 30, 2016 | 0.045M |
| March 31, 2016 | -0.031M |
| December 31, 2015 | 4.898M |
| September 30, 2015 | -0.042M |
| June 30, 2015 | -0.181M |
| March 31, 2015 | -0.225M |
| December 31, 2014 | 4.902M |
| September 30, 2014 | 4.853M |
| June 30, 2014 | 9.969M |
| March 31, 2014 | -0.049M |
| December 31, 2013 | -20.09M |
| September 30, 2013 | -0.21M |
| June 30, 2013 | 19.64M |
| March 31, 2013 | 19.50M |
| December 31, 2012 | -23.38M |
| September 30, 2012 | -5.522M |
| June 30, 2012 | -12.56M |
| March 31, 2012 | -0.548M |
| December 31, 2011 | -0.718M |
| September 30, 2011 | -0.333M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-15.25M
Minimum
Dec 2022
5.511M
Maximum
Dec 2023
-3.507M
Average
-0.20M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Kinnate Biopharma Inc (DELISTED) | 22.70M |
| Societal CDMO Inc (DELISTED) | -0.734M |
| Corcept Therapeutics Inc | 17.10M |
| Sarepta Therapeutics Inc | -64.36M |
| AbbVie Inc | -800.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.927M |
| Cash from Financing (Quarterly) | 124.49M |
| Free Cash Flow | -18.16M |
| Free Cash Flow Per Share (Quarterly) | -0.3419 |
| Free Cash Flow to Equity (Quarterly) | -127.99M |
| Free Cash Flow Yield | -5.99% |